In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 38 for your search:
Drug:  fentanyl citrate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Other
Protocol IDs: 4-2010-0368, NCT01234272

2.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 20110920A, NCT01499836

3.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 4-2007-0344, NCT01547416

4.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: Studio CERP, NCT01809106

5.

Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR014899, JNS020QD-JPN-C02, NCT00644787

6.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and older
Sponsor: NCI
Protocol IDs: NCCTG-889252, MAYO-889252, NCI-P91-0015

7.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: C25608/3039/BP/US, NCT00105287

8.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: 099-15, NCT00105937

9.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 17 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EN3267-005, NCT00262678

10.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 17 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EN3267-007, NCT00263575

11.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FEN-202, NCT00293020

12.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FEN-201, NCT00293033

13.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: FT-018-IM, 2005-002348-24, NCT00362583

14.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPO45/06/FCNS, NCT00458510

15.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPO43/06/FCNS, NCT00459277

16.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FT-019-IM, 2006-002087-26, NCT00496392

17.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0961, NCI-2012-01557, NCT00542542

18.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR014896, JNS020QD-JPN-C01, NCT00641667

19.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 20 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2246-0702, NCT00684632

20.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 20 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2246-0703, NCT00683995

21.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2246-004, NCT01326689

22.

Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NFCP1-2010, NCT01248611

23.

Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011-1007, NCT01515566

24.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 3 to 15
Sponsor: Pharmaceutical / Industry
Protocol IDs: C8278/2022/BP/US-CA, NCT00236093

25.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: FT-017-IM, 2005-002347-82, NCT00345735
1   
New Search